Results and Discussion
From a methanolic extract of the leaves of R. patula, 17 compounds (1-17) were isolated. The structures of the known compounds were determined to be b-sitosterol glucoside (6), 4) vanilloside (7), 5) bioside (decaffeoyl verbascoside) (8), 6) acteoside (verbascoside) (9), 7) syringin (10), 8) (11) , 9) cistanoside E (12), 10) roseoside (13), 11) phenethyl alcohol O-b -D-xylopyranosyl(1Љ→2Ј)-b -D-glucopyranoside (14) , 12) (ϩ)-lyoniresinol 3a-O-b-D-glucopyranoside (15), 13) isoacteoside (16), 14) and 3,4,5-trimethoxyphenol O-a-Lrhamnopyranosyl-(1Љ→6Ј)-b-D-glucopyranoside (17) 15) by comparing their spectroscopic data with those reported in the literature.
benzyl alcohol O-b-D-xylopyranosyl-(1Љ→2Ј)-b-D-glucopyranoside
Compound 1 was obtained as a pale yellow amorphous powder and had the molecular formula of C 23 H 22 O 13 which was established from the positive-ion mode high-resolution (HR)-electrospray ionization (ESI)-mass spectrometry (MS). The IR spectrum contained bands at 3330 cm Ϫ1 for a hydroxy group, 1700 and 1652 cm Ϫ1 for carbonyl groups, and 1614 cm Ϫ1 for an aromatic ring(s). The UV spectrum exhibited the characteristic absorptions at 348 (band I) and 235 (band II) nm for a flavonoid skeleton. 1 and the absolute configuration of the sugar was simultaneously determined to be of the D-series using a chiral detector. From the above evidence and the eleven degrees of unsaturation of the aglycone, 1 was expected to be a flavonoid b-Dgalacturonopyranoside with two methoxy groups. These physico-chemical data were in good agreement with those for structure of demethoxycentaureidin O-b-D-galacturonopyranoside (1). 17, 18) The bathochromic shifts of 30 nm for band I on the additions of AlCl 3 and AlCl 3 /HCl relative to the MeOH solution indicated the presence of a 5-hydroxy group (d H 12.90). While, on the addition of NaOMe, the insignificant bathochromic shift (27 nm) of band I, which was far less than 60 nm, as well as the absence of a band II shift on the addition of NaOAc indicated that the 4Ј-and 7-O-hydroxy groups must carry some substituents. 19) Further NMR analyses were performed, including 1 H-1 H correlation spectroscopy (COSY), and heteronuclear single quantum coherence (HSQC) and heteronuclear multiple-bound correlation (HMBC) spectroscopies. In the HMBC spectrum of 1, H-3 (d H 6.79) showed cross peaks with C-10, C-1Ј, C-2 and C-4 (d C 105.6, 122.8, 164.0 and 182.1, respectively), and the proton signal of H-8 (d H 6.97) showed cross peaks with C-10, C-6, C-9 and C-7 (d C 105.6, 132.5, 152.0 and 156.6, respectively) (Fig. 2) . Rare four bond couplings were observed be- Compound 2 was obtained as a pale yellow amorphous powder and it had the molecular formula of C 29 H 34 O 15 as determined by negative-ion mode HR-ESI-MS. The IR and UV spectra in methanol were similar to those of compound 1. The 13 C-NMR spectroscopic data for the A and C rings were essentially the same as those of 1, and in the C-NMR spectral data indicated that the terminal sugar was a-L-rhamnopyranoside. On the other hand, C-4Љ of the b-glucopyranosyl unit was shifted downfield, d C 76.0, suggesting that the interglycosidic linkage was (1→4), which was confirmed by the HMBC correlation between the anomeric proton (H-1ٞ) of the rhamnopyranosyl moiety at d H 5.23 and C-4Љ of the glucopyranosyl moiety. The HMBC spectroscopic data also displayed the correlation between the anomeric proton of the glucopyranosyl moiety (d H 5.28) and C-7 (d C 156.0) of the aglycone, being an evidence that the glycosylation had occurred at the hydroxyl group at C-7. On the basis of these spectral data, the structure of compound 2 was elucidated to be 5,7-dihydroxy- Fig. 1 .
Compound 3 was obtained as a pale yellow amorphous powder and exhibited the molecular formula of C 29 H 32 O 16 , which was determined by positive-ion mode HR-ESI-MS. Compound 3 was an analogous compound to 2, except for the presence of a substituted b-glucuronopyranosyl moiety, instead of the 4Љ-substituted glucopyranose that was seen in 2. The absolute configurations of these sugars were determined to be of the D-series. The HMBC spectrum also confirmed the glycosidic linkage to the hydroxy group at the C-7 position, since H-1ٞ signal of the rhamnose at d H 5.26 was coupled with C-4Љ of the glucuronic acid at d C 75.9. Therefore, the structure of compound 3 was elucidated to be 5,7- Fig. 1 .
Compound 4 was obtained as an amorphous powder and its elemental composition was determined to be C 19 C-NMR spectral data of compound 4 showed a remarkable similarity to those of the known megastigmane glucoside byzantionoside B (18) , except for the carbon signal at the 6Ј-position of the b-glucopyranosyl moiety (Table 2) . 21, 22) The downfield shift exhibited by the 6Ј-position of the b-glucopyranosyl moiety suggested the attachment of some substituent at this position, which was confirmed by measurement of mass spectra. The ESI-MS spectra showed a single peak at m/z 497.1424 in the positive-mode and m/z 451.1985 in the negative-mode corresponding to C 19 Compound 5 was obtained as a white amorphous powder and it had the molecular formula of C 17 H 30 O 10 , which was deduced from positive-ion mode HR-ESI-MS. The aglycone portion consisted of six carbons; one terminal methyl, two olefinic, two methylene and one oxymethylene carbon. Considering the coupling patterns observed on 1 H-NMR spectroscopy, the structure of the aglycone portion was determined to be hex-3-en-l-o1. The geometry of the double bond was determined to be cis by comparison of the 13 C-NMR chemical shifts with those of the reported (Z)-hex-3-en-1-o1. 23 (Table 2) .
16) The linkage of these sugars was determined to be xylopyranosyl-(1→2)-glucopyranoside, because a 13 C-NMR signal that was assignable to the 2-position of glucose was significantly shifted downfield (d C 83.2) compared with that of an unsubstituted b-glucopyranoside 24) and the HMBC spectrum also supported the position of linkage. Accordingly, the structure of compound 5 was determined to be ( Fig. 1 .
Flavonoids and phenylethanoids were isolated from R. patula. Structurally related aglycone of compound 1, centaureidin, was reported to possess antioxidant activity 25) and com- mon aglycone of compounds 2 and 3, pectolinarigenin, is also known to have a preventing activity of hepatic injury caused by D-galactosamine via antioxidant mechanism. 26) Phenylethanoids were also reported to have radical scavenging acitivity.
27)

Experimental
General Experimental Procedures Optical rotation data were measured on a JASCO P-1030 polarimeter. IR and UV spectra were obtained on a Horiba FT-710 Fourier transform infrared spectrophotometer and a JASCO V-520 UV/Vis spectrophotometer, respectively.
1 H-and 13 C-NMR spectra were recorded on a JEOL JNM a-400 spectrometer with tetramethylsilane as an internal standard. A circular dichroism (CD) spectrum was measured on a JASCO J-720 spectropolarimeter. HR-ESI mass spectra were taken on LTQ Orbitrap XL and QSTAR XL mass spectrometers. Extraction and Isolation Powdered air-dried leaves (2.80 kg) of R. patula was exhaustively extracted with 70% methanol (5 lϫ5) and then concentrated under reduced pressure to yield a viscous gummy material. This residue (330 g) was dissolved in 250 ml of water and defatted with n-hexane (1 lϫ5). The aqueous layer was evaporated to remove a trace amount of organic solvent, and then extracted with EtOAc and 1-BuOH, successively (1 lϫ5 each). The EtOAc and 1-BuOH fractions were concentrated under reduced pressure to give 14 g and 137 g of residues, respectively. The remaining aqueous layer was concentrated to furnish a water-soluble fraction (60 g).
The EtOAc fraction (14 g) was subjected to silica gel CC (520 g) (Fϭ 55 mm, Lϭ60 cm). The column was eluted initially with CHCl 3 (5 l), and then with a CHCl 3 -MeOH gradient mixture, 500 ml fractions being collected. Similar fractions were combined, affording 16 fractions. The second fraction was precipitated with MeOH to provide 6 (35 mg).
The 1-BuOH fraction (137 g) was fractionated by CC on a highly porous synthetic resin, Diaion HP-20 (Fϭ40 mm, Lϭ55 cm). The column was eluted initially with H 2 O (3 l) and then with a MeOH-H 2 O stepwise gradient of increasing MeOH content, i.e., 20% (2 l), 50% (2 l), 80% (2 l), and 100% MeOH (3 l). The effluent was collected in fractions (500 ml each). Similar fractions were combined to provide three fractions. The first fraction (I) eluted with 20% MeOH (4.33 g) was subjected to silica gel CC (160 g) (Fϭ30 mm, Lϭ50 cm), using CHCl 3 -MeOH gradients, yielding six fractions. The fourth fraction, I-4 (316 mg), was purified by DCCC to give three fractions. The second fraction, I-4-2 (256 mg), was purified by HPLC to produce compound 7 (6.56 mg) and compound 8 (2.48 mg). The fifth fraction, I-5 (1.13 g), was purified by RPCC, affording four fractions. The fourth fraction, I-5-4 (219.9 mg), was subjected to DCCC to give three fractions. The second fraction, I-5-4-2 (108.2 mg), was purified by HPLC to furnish compound 4 (34.6 mg).
The second fraction (II) eluted with 50% MeOH (6.36 g) on Diaion HP-20 CC was chromatographed on silica gel (350 g), (Fϭ40 mm, Lϭ55 cm), using a CHCl 3 -MeOH gradient system, 200 ml fractions being collected. Similar fractions were combined to yield seven fractions. The seventh fraction, II-7 (4.65 g), was purified by RPCC, producing five fractions. The third fraction, II-7-3 (1.58 g), was subjected to silica gel (75 g) CC with isocratic elution with CHCl 3 -MeOH-H 2 O (17 : 6 : 1), providing seven fractions. The fourth fraction, II-7-3-4 (124 mg), was purified by HPLC to furnish compound 1 (10 mg) and compound 2 (21.1 mg). The fourth fraction, II-7-4 (1.63 g), was subjected to silica gel (75 g) CC using an isocratic system of CHCl 3 -MeOH-H 2 O (17 : 6 : 1), giving five fractions. The third fraction II-7-4-3 (123.4 mg) was purified by HPLC to afford compound 9 (7 mg).
The last fraction (III) eluted with 80% MeOH (5.0 g) was subjected to silica gel CC (200 g) (Fϭ35 mm, Lϭ60 cm), using CHCl 3 -MeOH mixtures, yielding seven fractions. The third fraction, III-3 (500 mg), was purified by RPCC, affording nine fractions. The third fraction, III-3-3 (13.4 mg), was purified by HPLC to yield compound 10 (4.1 mg) and compound 11 (5.2 mg). The fourth fraction, III-3-4 (15.3 mg), was purified by HPLC to give compound 12 (3.2 mg) and compound 13 (10.4 mg) . The fifth fraction, III-3-5 (78.4 mg), was purified by HPLC to furnish compound 14 (5.7 mg) and compound 5 (4 mg). The sixth fraction, III-3-6 (31.5 mg), was purified by HPLC to yield compound 15 (8 mg) . The ninth fraction, III-3-9 (98 mg), was subjected to DCCC, giving three fractions. The second fraction, III-3-9-2 (16 mg), was purified by HPLC to afford compound 16 (2.3 mg). The fourth fraction, III-4 (953 mg), was purified by RPCC, producing three fractions. The third fraction, III-4-3 (101 mg), was purified by HPLC to give compound 17 (5.5 mg). The fifth fraction, III-5 (82.7 mg), was subjected to silica gel (50 g) CC using an isocratic system of CHCl 3 -MeOH-H 2 O (17 : 6 : 1), affording five fractions. The fifth fraction, III-5-5 (40 mg), was purified by HPLC to furnish compound 3 (4.8 mg).
Demethoxycentaureidin 
